MedTrace Logo

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

NCT07742878 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-08-03

No results posted yet for this study

Summary

The early prospective study of Traq™ (an investigational binocular ophthalmic neurodiagnostic device) will measure binocular ocular functions (bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency) in normal subjects and those with history of mild-to moderate traumatic brain injury (mTBI).

Conditions

  • Mild Traumatic Brain Injury, Concussion
  • Binocular Visual Function
  • Neuro-Ophthalmology
  • Saccadic Eye Movements

Interventions

DEVICE

Binocular ophthalmic neurodiagnostic device

Participants will undergo non-invasive binocular ophthalmic neurodiagnostic measurements and ocular assessments. No treatment or intervention will be administered as part of the study.

Sponsors & Collaborators

  • Rebiscan, Inc.

    lead INDUSTRY

Principal Investigators

  • Heidi Bell, OD · Elite Eye Car / Elite Vision Therapy

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-14
Primary Completion
2026-10-31
Completion
2026-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07742878 on ClinicalTrials.gov